Middle East and Africa Percutaneous Mechanical Circulatory Support Devices Market Share by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Middle East and Africa Percutaneous Mechanical Circulatory Support Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Intra-Aortic Balloon Pumps, VA-Extracorporeal Membrane Oxygenators (ECMO), and Short-Term Ventricular Assist Devices); End User (Hospitals, Ambulatory Surgical Centers, and Others); and Country

  • Report Date : Jan 2021
  • Report Code : TIPRE00018227
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 96

The Middle East & Africa percutaneous mechanical circulatory support devices market is expected to reach US$ 203.79 million by 2027 from US$ 81.34 million in 2019; it is estimated to grow at a CAGR of 12.5% from 2020 to 2027.

The rising geriatric population, and increasing prevalence of cardiovascular diseases are the key factors driving the growth of percutaneous mechanical circulatory support devices. However, high costs of these devices and procedures associated with them, and impact of COVID-19 pandemic on medical device industry is the major factor hindering the Percutaneous mechanical circulatory support devices market growth in Middle East & Africa.

Percutaneous mechanical circulatory support devices offer an effective and rapid approach to slow the downward spiral of hemodynamic instability among patients suffering with decompensated heart failures and cardiogenic shocks till a more definitive strategy is perceived among patients to recover from these cardiac ailments. The major roles of the percutaneous mechanical circulatory support devices include improving the native cardiac output, reducing ventricular volume and filling pressures, augmenting coronary perfusion, and maintaining vital organ perfusion.

Improvements in the surgical techniques coupled with quality of implantable valves have led to substantial growth in the volume of valve replacement procedures performed. The rising prevalence of these surgeries helps to save more lives and subsequently provide better quality of health and life to the patients suffering from congenital heart diseases (CHDs). Various Middle East & Africa countries are offering medical reimbursements for medical procedures involving valve replacement. Improvements in health care policies, with reimbursement policies for the population have ensured an increased life expectancy. Thus, the increasing reimbursement for these procedures is likely to increase their volumes and be a prevalent trend in the market during the forecast period.

The healthcare infrastructure in large cities of developing countries may have all the necessary amenities, but rural areas may not. Thus, these massive unexplored areas pose as ample revenue generation opportunities for percutaneous mechanical circulatory support devices market, as cardiovascular diseases are among the prominently prevalent health conditions within these economies. Countries like UAE and Saudi Arabia have a large patient population base, and the healthcare expenditure is increasing, thus illustrating immense healthcare market potential. Thus, with the growing healthcare industry and increasing government initiatives, the demand for percutaneous mechanical circulatory support devices is expected to increase in the developing economies.

COVID-19 pandemic is making its way to all Middle East & Africa countries. Due to growing COVID-19, these countries are expecting to witness a huge challenge and are expected to affect largely to healthcare industries in the current situation. In Saudi Arabia, it has been reported that the confirmed cases has been increased to 21,400 and death rate has been low with 160 numbers. These numbers are changing owing to various factors such as the prevalence of chronic disease patients, surgeries, population density in regions, and other factors. Restrictive measures have been taken to control the spread of this pandemic. Moreover, due to surgeries, the number of COVID-19 numbers is also growing. This pandemic is affecting the business operation of the various key players operating in this region.

Rest of Middle East & Africa Percutaneous Mechanical Circulatory Support Devices Market, Revenue and Forecast to 2027 (US$ Mn)

Rest of Middle East & Africa Percutaneous Mechanical Circulatory Support Devices Market, Revenue and Forecast to 2027 (US$ Mn)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL CIRCULATORY SUPPORT DEVICES MARKET SEGMENTATION

By Product

  • Intra-Aortic Balloon Pumps
  • VA-Extracorporeal Membrane Oxygenation (ECMO)
  • Short-Term Ventricular Assist Devices (VADs)
    • Impella
    • Tandem Heart

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Country

  • UAE
  • Saudi Arabia
  • South Africa

Company Profiles

  • Abbott
  • Livanova Plc (Cardiacassist, Inc)
  • Eurosets
  • Berlin Heart
  • Medtronic

Middle East and Africa Percutaneous Mechanical Circulatory Support Devices Report Scope

Report Attribute Details
Market size in 2019 US$ 81.34 Million
Market Size by 2027 US$ 203.79 Million
Global CAGR (2020 - 2027) 12.5%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Intra-Aortic Balloon Pumps
  • VA-Extracorporeal Membrane Oxygenators
  • Short-Term Ventricular Assist Devices
By End User
  • Hospitals
  • Ambulatory Surgical Centers
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • Livanova Plc (Cardiacassist, Inc)
  • Eurosets
  • Berlin Heart
  • Medtronic
  • Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Middle East and Africa Percutaneous Mechanical Circulatory Support Devices Market

    1. Abbott
    2. Livanova Plc (Cardiacassist, Inc)
    3. Eurosets
    4. Berlin Heart
    5. Medtronic
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo